| Schedule of Significant Expense Categories of the Company’s Single Operating Segment |
The following table presents the significant expense categories of the Company’s single operating segment for the periods presented. | | | For the Three Months Ended
June 30, | | | For the Six Months Ended June 30, | | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | | | (Unaudited) | | | (Unaudited) | | | (Unaudited) | | | (Unaudited) | | | Operating expenses and other expenses: | | | | | | | | | | | | | | Clinical trial related service fee to related party (Note 5) | | $ | 1,375,000 | | | $ | 4,625,000 | | | $ | 2,750,000 | | | $ | 6,000,000 | | | Consulting fee | | | 15,000 | | | | 25,000 | | | | 30,000 | | | | 50,000 | | | Stock-based compensation (Note 8) | | | 145,298 | | | | 159,098 | | | | 292,012 | | | | 318,193 | | | Salary expense | | | 131,272 | | | | 131,096 | | | | 260,036 | | | | 260,807 | | | Professional fee | | | 289,932 | | | | 475,437 | | | | 688,065 | | | | 760,527 | | | Insurance expense | | | 81,850 | | | | 83,636 | | | | 161,189 | | | | 164,693 | | | Other general and administrative fee | | | 45,895 | | | | 44,761 | | | | 86,382 | | | | 94,106 | | | Change in fair value of derivative liabilities | | | 222,092 | | | | - | | | | 330,719 | | | | - | | | Loss before income tax | | | 2,306,339 | | | | 5,544,028 | | | | 4,598,403 | | | | 7,648,326 | | | | | | | | | | | | | | | | | | | | | Income tax expense | | | - | | | | 850 | | | | - | | | | 863 | | | Net loss | | $ | 2,306,339 | | | $ | 5,544,878 | | | $ | 4,598,403 | | | $ | 7,649,189 | |
|